intellectual developmental disorder and retinitis pigmentosa; IDDRP
disease diseaseOn this page
Also known as IDDRP
Summary
intellectual developmental disorder and retinitis pigmentosa; IDDRP (MONDO:0032594) is a disease caused by SCAPER (GenCC Strong), with 1 cohort gene.
At a glance
- Causal gene: SCAPER (GenCC Strong)
- Cohort genes: 1
- ClinVar variants: 46
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | intellectual developmental disorder and retinitis pigmentosa; IDDRP |
| Mondo ID | MONDO:0032594 |
| OMIM | 618195 |
| UMLS | C4748658 |
| MedGen | 1648358 |
| GARD | 0016306 |
| Is cancer (heuristic) | no |
Also known as: IDDRP
Data availability: 46 ClinVar variants · 3 GenCC gene-disease records.
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › neurodevelopmental disorder › intellectual disability › intellectual developmental disorder and retinitis pigmentosa; IDDRP
Related subtypes (9): syndromic intellectual disability, non-syndromic intellectual disability, PPP2R1A-related intellectual disability, intellectual disability, autosomal dominant, X-linked intellectual disability, intellectual disability, autosomal recessive, NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability, SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth, intellectual developmental disorder with polymicrogyria and seizures
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
46 retrieved; paginated sample, class counts are floors:
15 likely pathogenic, 13 uncertain significance, 8 benign, 6 pathogenic, 2 pathogenic/likely pathogenic, 1 conflicting classifications of pathogenicity, 1 benign/likely benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 3544437 | NM_020843.4(SCAPER):c.1461_1462insGTGGTATATCC (p.Met488fs) | SCAPER | Pathogenic | criteria provided, single submitter |
| 417685 | NM_020843.3(SCAPER):c.2973_2976del (p.Ile991Metfs) | SCAPER | Pathogenic | criteria provided, single submitter |
| 424861 | NM_020843.4(SCAPER):c.2023-2A>G | SCAPER | Pathogenic | no assertion criteria provided |
| 427855 | NM_020843.4(SCAPER):c.3656G>A (p.Ser1219Asn) | SCAPER | Pathogenic/Likely pathogenic | no assertion criteria provided |
| 427856 | NM_020843.3(SCAPER):c.1859_1861del (p.Glu620del) | SCAPER | Pathogenic/Likely pathogenic | no assertion criteria provided |
| 620525 | NM_020843.4(SCAPER):c.2377C>T (p.Gln793Ter) | SCAPER | Pathogenic | criteria provided, single submitter |
| 800544 | NM_020843.4(SCAPER):c.2236dup (p.Ile746fs) | SCAPER | Pathogenic | criteria provided, single submitter |
| 800545 | NM_020843.4(SCAPER):c.2179C>T (p.Arg727Ter) | SCAPER | Pathogenic | criteria provided, single submitter |
| 800548 | NM_020843.4(SCAPER):c.3224del (p.Pro1075fs) | LOC126862183 | Likely pathogenic | no assertion criteria provided |
| 1325035 | NM_020843.4(SCAPER):c.2961_2962del (p.Cys988fs) | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 1325036 | NM_020843.4(SCAPER):c.2955-1G>T | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 1334384 | NM_020843.4(SCAPER):c.334C>T (p.Arg112Ter) | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 1676479 | NM_020843.4(SCAPER):c.125-1G>A | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 3065980 | NM_020843.4(SCAPER):c.2364T>A (p.Tyr788Ter) | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 3248655 | NM_020843.4(SCAPER):c.2613dup (p.Ala872fs) | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 4087726 | NM_020843.4(SCAPER):c.2605A>T (p.Lys869Ter) | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 800546 | NM_020843.4(SCAPER):c.1116del (p.Val373fs) | SCAPER | Likely pathogenic | no assertion criteria provided |
| 800547 | NM_020843.4(SCAPER):c.1495+1G>A | SCAPER | Likely pathogenic | no assertion criteria provided |
| 800549 | NM_020843.4(SCAPER):c.829C>T (p.Arg277Ter) | SCAPER | Likely pathogenic | no assertion criteria provided |
| 800550 | NM_020843.4(SCAPER):c.3707_3708del (p.Ser1236fs) | SCAPER | Likely pathogenic | no assertion criteria provided |
| 800551 | NM_020843.4(SCAPER):c.2166-3C>G | SCAPER | Likely pathogenic | no assertion criteria provided |
| 829945 | NM_020843.4(SCAPER):c.2653del (p.Glu885fs) | SCAPER | Likely pathogenic | no assertion criteria provided |
| 829946 | NM_020843.4(SCAPER):c.1081C>T (p.Arg361Ter) | SCAPER | Likely pathogenic | criteria provided, single submitter |
| 2400307 | NM_020843.4(SCAPER):c.3431A>G (p.His1144Arg) | SCAPER | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 2595022 | NM_020843.4(SCAPER):c.3113G>A (p.Gly1038Glu) | LOC126862183 | Uncertain significance | criteria provided, multiple submitters, no conflicts |
| 1184367 | NM_020843.4(SCAPER):c.3065T>C (p.Ile1022Thr) | SCAPER | Uncertain significance | criteria provided, single submitter |
| 1727209 | NM_020843.4(SCAPER):c.213T>G (p.Cys71Trp) | SCAPER | Uncertain significance | criteria provided, single submitter |
| 2435661 | NM_020843.4(SCAPER):c.1883T>C (p.Phe628Ser) | SCAPER | Uncertain significance | criteria provided, single submitter |
| 2435662 | NM_020843.4(SCAPER):c.1382A>T (p.Asp461Val) | SCAPER | Uncertain significance | criteria provided, single submitter |
| 2435663 | NM_020843.4(SCAPER):c.1250C>T (p.Ser417Phe) | SCAPER | Uncertain significance | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 6 · Orphanet: 2 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| SCAPER | Strong | Autosomal recessive | intellectual developmental disorder and retinitis pigmentosa; IDDRP | 6 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| SCAPER | Orphanet:110 | Bardet-Biedl syndrome |
| SCAPER | Orphanet:791 | Retinitis pigmentosa |
Cohort genes → proteins
1 cohort genes, 1 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 1 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| SCAPER | HGNC:13081 | ENSG00000140386 | Q9BY12 | S phase cyclin A-associated protein in the endoplasmic reticulum | gencc,clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| SCAPER | S phase cyclin A-associated protein in the endoplasmic reticulum | CCNA2/CDK2 regulatory protein that transiently maintains CCNA2 in the cytoplasm. |
Protein-family classification
Druggable: 0 · Difficult: 1 · Unknown: 0 · Druggable fraction: 0.0
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Transcription factor | 1 | 8.3× | 0.121 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| SCAPER | Transcription factor | no | Matrin/U1-like-C_Znf_C2H2, Znf_C2H2_type, SCAPER_N |
Expression context
Cohort genes with no expression data: 0.
1 cohort gene are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 1 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| cortical plate | 1 |
| male germ line stem cell (sensu Vertebrata) in testis | 1 |
| sural nerve | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| SCAPER | 282 | ubiquitous | marker | cortical plate, male germ line stem cell (sensu Vertebrata) in testis, sural nerve |
Protein interactions among cohort
Intra-cohort edges: 0.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| SCAPER | 711 |
Structural data
PDB: 1 · AlphaFold-only: 0 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| SCAPER | Q9BY12 | 2 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 0. Enrichment computed across 1 evidence-associated genes (0 with Reactome annotation).
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| antral ovarian follicle growth | 1 | 3370.4× | 0.001 | SCAPER |
| seminiferous tubule development | 1 | 766.0× | 0.003 | SCAPER |
| retina development in camera-type eye | 1 | 255.3× | 0.005 | SCAPER |
| spermatogenesis | 1 | 35.2× | 0.028 | SCAPER |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1
Druggability breadth: 0 of 1 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| SCAPER | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Pharmacogenomics
Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 0 | |
| E | Difficult family or no structure, no drug | 1 | SCAPER |
Undrugged target profiles
1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| SCAPER | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
- Cohort genes: SCAPER